Pharmaceutical companies Merck and Ridgeback Biotherapeutics have published an update on molnupiravir, a pill formulated to help treat COVID...
Pharmaceutical companies Merck and Ridgeback Biotherapeutics have published an update on molnupiravir, a pill formulated to help treat COVID-19 by reducing one’s risk of being hospitalized with or dying from the disease. According to the latest details from the company, molnupiravir isn’t quite as effective as the interim analysis had previously found. Merck and Ridgeback published the update on the … Continue reading
from SlashGear https://ift.tt/3E9L1LG
via IFTTT
from SlashGear https://ift.tt/3E9L1LG
via IFTTT
COMMENTS